Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × thymoglobulin × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 3 Leukemia, Myelomonocytic, Juvenile 3 beta-Thalassemia 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Anemia, Refractory, with Excess of Blasts 2 Vasculitis, Central Nervous System 1 Thalassemia 1 Stiff-Person Syndrome 1 Shwachman-Diamond Syndrome 1 Sarcoma, Myeloid 1 Rhabdomyosarcoma 1 Rasmussen subacute encephalitis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Non-Malignant Neoplasm 1 Neuromyelitis Optica 1 Neurofibrosarcoma 1 Neurofibromatosis 1 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myeloid Diseases 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡